YU47943B - Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja - Google Patents

Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja

Info

Publication number
YU47943B
YU47943B YU20690A YU20690A YU47943B YU 47943 B YU47943 B YU 47943B YU 20690 A YU20690 A YU 20690A YU 20690 A YU20690 A YU 20690A YU 47943 B YU47943 B YU 47943B
Authority
YU
Yugoslavia
Prior art keywords
benzyl
indazole
hydroxymethyl
hydroxy acids
aliphatic
Prior art date
Application number
YU20690A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU20690A (sh
Inventor
B. Sil Vestrini
L. Baiocchi
Original Assignee
Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chemiche Riunite Agelini Francesco A.C.R.A.F. S.P.A.
Priority to SI9010206A priority Critical patent/SI9010206A/sl
Publication of YU20690A publication Critical patent/YU20690A/sh
Priority to HRP-206/90A priority patent/HRP940878B1/xx
Publication of YU47943B publication Critical patent/YU47943B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
YU20690A 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja YU47943B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9010206A SI9010206A (sl) 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola z alifatskimi 2-hidroksi kislinami
HRP-206/90A HRP940878B1 (en) 1989-02-07 1994-10-28 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
YU20690A YU20690A (sh) 1992-07-20
YU47943B true YU47943B (sh) 1996-07-24

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20690A YU47943B (sh) 1989-02-07 1990-02-05 Etri 1-benzil-3-hidroksimetil-indazola sa alifatičnim 2-hidroksi kiselinama i postupak dobijanja

Country Status (36)

Country Link
US (2) US4999367A (enExample)
EP (1) EP0382276B1 (enExample)
JP (1) JP2870925B2 (enExample)
KR (1) KR0145525B1 (enExample)
CN (2) CN1046505C (enExample)
AR (1) AR247386A1 (enExample)
AT (1) ATE127115T1 (enExample)
AU (1) AU624895B2 (enExample)
BG (1) BG50273A3 (enExample)
CA (1) CA2009503C (enExample)
CZ (1) CZ280121B6 (enExample)
DD (2) DD295363A5 (enExample)
DE (2) DE69021902T2 (enExample)
DK (1) DK0382276T3 (enExample)
EG (1) EG19170A (enExample)
ES (1) ES2020171T3 (enExample)
FI (1) FI102678B1 (enExample)
GE (1) GEP19971030B (enExample)
GR (2) GR910300073T1 (enExample)
HU (1) HU204793B (enExample)
IL (1) IL93132A (enExample)
IN (1) IN170957B (enExample)
IT (1) IT1230441B (enExample)
LT (1) LT3604B (enExample)
LV (1) LV10612B (enExample)
NZ (1) NZ232258A (enExample)
PE (1) PE25091A1 (enExample)
PH (1) PH26552A (enExample)
PL (2) PL163720B1 (enExample)
PT (1) PT93067B (enExample)
RO (1) RO106252B1 (enExample)
RU (3) RU2066318C1 (enExample)
SK (1) SK278441B6 (enExample)
UA (1) UA26852C2 (enExample)
YU (1) YU47943B (enExample)
ZA (1) ZA90644B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EA018185B1 (ru) 2008-03-07 2013-06-28 Ацьенде Кимике Рьюните Анджелини Франческо A.К.P.A.Ф. С.П.А. Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 или cx3cr1
DK2254869T3 (en) 2008-03-07 2017-09-04 Acraf 1-BENZYL-3-HYDROXYMETHYL INDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF CX3CR1 AND P40
MX2010009625A (es) 2008-03-07 2010-09-28 Acraf Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
BR112012002130A2 (pt) * 2009-08-03 2015-09-15 Aziende Chimique Riunite Angelini Francesco A C R A F S P A processo para a preparação de composto,e, composto intermediário
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
DK2882715T3 (en) 2012-05-18 2017-02-13 Sanofi Sa PYRAZOL DERIVATIVES AND USE THEREOF AS LPAR5 ANTAGONISTS
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
AU2019441740B2 (en) 2019-04-18 2025-12-18 Tracery Ophthalmics Inc. Detection, prediction, and classification for ocular disease
EP3990433B1 (en) * 2019-06-25 2026-05-20 Translatum Medicus Inc. PROCESSES FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
UA26852C2 (uk) 1999-12-29
RU2044729C1 (ru) 1995-09-27
CA2009503A1 (en) 1990-08-07
CA2009503C (en) 2000-04-11
DE69021902T2 (de) 1996-05-23
ATE127115T1 (de) 1995-09-15
DK0382276T3 (da) 1996-01-15
SK56390A3 (en) 1997-05-07
KR0145525B1 (ko) 1998-08-17
PL163720B1 (pl) 1994-04-29
IL93132A (en) 1994-05-30
SK278441B6 (en) 1997-05-07
BG50273A3 (en) 1992-06-15
AU4906690A (en) 1990-08-16
US5112986A (en) 1992-05-12
EG19170A (en) 1994-11-30
DD295363A5 (de) 1991-10-31
PL163730B1 (pl) 1994-04-29
EP0382276B1 (en) 1995-08-30
ES2020171A4 (es) 1991-08-01
PT93067A (pt) 1990-08-31
DD291995A5 (de) 1991-07-18
HU204793B (en) 1992-02-28
RO106252B1 (ro) 1993-03-31
LT3604B (en) 1995-12-27
PH26552A (en) 1992-08-19
CN1046505C (zh) 1999-11-17
IN170957B (enExample) 1992-06-20
CZ280121B6 (cs) 1995-11-15
JP2870925B2 (ja) 1999-03-17
FI900577A0 (fi) 1990-02-06
JPH02240065A (ja) 1990-09-25
RU2066318C1 (ru) 1996-09-10
EP0382276A3 (en) 1990-12-12
US4999367A (en) 1991-03-12
LTIP872A (en) 1995-03-27
DE69021902D1 (de) 1995-10-05
GR910300073T1 (en) 1991-11-15
PE25091A1 (es) 1991-08-17
HUT53088A (en) 1990-09-28
PT93067B (pt) 1995-12-29
YU20690A (sh) 1992-07-20
LV10612A (lv) 1995-04-20
IT1230441B (it) 1991-10-23
CN1088201A (zh) 1994-06-22
FI102678B (fi) 1999-01-29
EP0382276A2 (en) 1990-08-16
CZ56390A3 (en) 1995-06-14
ZA90644B (en) 1991-01-30
RU2055071C1 (ru) 1996-02-27
HU900689D0 (en) 1990-04-28
DE382276T1 (de) 1991-11-28
NZ232258A (en) 1991-06-25
KR900012913A (ko) 1990-09-03
AU624895B2 (en) 1992-06-25
IT8947620A0 (it) 1989-02-07
AR247386A1 (es) 1994-12-29
CN1034016C (zh) 1997-02-12
CN1044810A (zh) 1990-08-22
GR3018165T3 (en) 1996-02-29
IL93132A0 (en) 1990-11-05
ES2020171T3 (es) 1995-12-01
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
LV10612B (en) 1995-08-20

Similar Documents

Publication Publication Date Title
MY131271A (en) Liquid detergents with an aryl boronic acid for inhibition of proteolytic enzyme
GB1423006A (en) Herbicidal compositions containing 4-phenoxy-phenoxy-propionic acid derivatives
WO1991013055A3 (en) New aryl- and heteroarylethenylene derivatives and process for their preparation
YU46414B (sh) Postupak za dobivanje hinolinskih derivata
AU528275B2 (en) Imidazole derivatives
YU46541B (sh) Postupak za dobijanje antiaritmičkih agenasa
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
YU30492A (sh) Derivati piperidina i postupci za njihovo dobijanje
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
YU185787A (sh) Novi derivati oksadiazol-alkil-purina i postupak za njihovo dobijanje
YU15291A (sh) Herbicidni uracili tipa estara cimetne kiseline
ES2000779A6 (es) Un procedimiento para preparar derivados de piridazinona y metodo para reprimir plagas de insectos usando dichos derivados.
ES2059625T3 (es) Un procedimiento para preparar un derivado de hidroxialquilcisteina.
CA2009503A1 (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
YU45810B (sh) Postupak za dobijanje hinolin karboksilnih kiselina
MY101261A (en) New 4-pyridone derivatives, method of their production and their pharmaceutical compositions.
GB1285400A (en) Esters of substituted anthranilic acid
SE8403268L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES8603193A1 (es) Procedimiento para preparar nuevos esteres de estriol
ES468658A1 (es) Un procedimiento para preparar 4-alcohiltio-2-trifluorome- tilalcanosulfonanilidas y sus derivados
GR861205B (en) Method for preparing hexenoic acids
YU46483B (sh) Postupak za dobijanje kondenzovanih derivata pirimidina
YU47508B (sh) Novi feniletanolamino derivati i postupak za njihovo dobijanje
EP0067561A3 (en) Piperazine derivatives and processes for producing them